This inventor holds 2 USPTO granted patents. Top assignee: Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: He Tian - Innovator in Pharmaceutical Development
Introduction
He Tian is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. His work is crucial in advancing treatments for diseases mediated by AKT protein kinase.
Latest Patents
He Tian holds a patent for an AKT inhibitor. This invention specifically relates to a compound represented by formula I or a pharmaceutically acceptable salt thereof. The patent also outlines a preparation method for the compound and its use in the prevention and/or treatment of diseases mediated by AKT protein kinase. He has 1 patent to his name.
Career Highlights
He Tian is associated with Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., where he has been instrumental in research and development. His innovative approach has led to advancements in pharmaceutical formulations and therapeutic applications.
Collaborations
He has collaborated with notable colleagues, including Changyou Ma and Jie An, who have contributed to his research endeavors. Their teamwork has fostered a productive environment for innovation and discovery.
Conclusion
He Tian's work in developing AKT inhibitors showcases his commitment to advancing medical science. His contributions are vital for the ongoing fight against diseases influenced by AKT protein kinase.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile